Most Popular

Check out the most popular stories and multimedia features across the site right now

Fish oil capsules close-up

Health

Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate

By Matthew Herper

Health

Next for Apple Watch: a ‘pragmatic’ clinical trial with J&J to track heart health

By Matthew Herper

advertisement

Apple Watch 4

Health

Giant study shows Apple Watch can spot heart rhythm changes — but it’s far from ‘medical-grade technology’

By Matthew Herper

advertisement

Red blood cells

Biotech

Tiny PhaseBio gets the New England Journal’s spotlight. Can its shares rebound?

By Matthew Herper

Medical syringe

Biotech

A Regeneron drug dominates eczema treatment. With new data, a small biotech believes it can compete

By Adam Feuerstein

Plasmodium vivax

Health

An AIDS therapy involving parasite injections was discredited. China is reviving it — for cancer

By Jane Qiu

VASOSTRICT illo

Politics

An ICU staple has exponentially spiked in price. Can compounding solve that problem? Now the courts will decide

By Nicholas Florko

advertisement

Don't Miss

Vote now: Pick the best ideas in biomedical science

By STAT

advertisement

The capitol at sunrise

Politics

Powerful Medicare advisory group criticizes Congress for ‘donut hole’ changes

By Nicholas Florko

Butembo

Health

CDC’s Redfield: It could take another year to control Ebola in DRC

By Helen Branswell

UnitedHealth

First Opinion

Landmark ruling sets precedent for parity coverage of mental health and addiction treatment

By Patrick J. Kennedy and Jim Ramstad

Single vial of blood

First Opinion

Liquid biopsy research should include the perspectives of patients like me

By Grace Cordovano

Haven

Business

What’s in a name? For the newly christened Haven, maybe another legal fight

By Casey Ross and Kate Sheridan

CAR-T

Health

Hospitals are saving lives with CAR-T. Getting paid is another story

By Ike Swetlitz

Clogged Artery

Biotech

New results show benefits of Esperion’s cholesterol drug — but leave big questions unanswered

By Matthew Herper

Apple health watch

First Opinion

Beware the hype over the Apple Watch heart app. The device could do more harm than good

By Larry Husten

Calculator

First Opinion

Value extends beyond the cost of drugs and health care

By Jennifer Bright and Mark Linthicum

Intermountain Healthcare - central pharmacy

First Opinion

How the not-for-profit Civica Rx will disrupt the generic drug industry

By Marc Harrison

Vintage eggs and toast

Health

Are eggs good or bad for you? New research rekindles the debate

By Associated Press